Evidence map›Paper›PMID 38600163›Full record

ArticleBone marrow transplantation2024

Insulin eye drops for severe refractory chronic ocular graft-versus-host disease.

V Tahmaz, L Menghesha, M E Stern, U Holtick, C Scheid, P Steven

Registry-linked trialAbstract readLetter
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06939959 (Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06939959 phase4completednot on this mapstarted 2025, after this paper: background citation

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease

TypeinterventionalSponsorKhyber Teaching HospitalRan2025 to 2026Enrolled128ConditionsDry Eye, Insulin SensitivityArmsArtificial tear, insulin human
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Repair of Corneal Epithelial Defects.Progress in molecular and subcellular biology · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

V TahmazCompetence Center for Ocular GvHD, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Volkan.tahmaz@uk-koeln.de.ORCID http://orcid.org/0000-0002-7939-4027
L MengheshaCompetence Center for Ocular GvHD, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
M E SternCompetence Center for Ocular GvHD, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
U HoltickDepartment of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
C ScheidDepartment of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
P StevenCompetence Center for Ocular GvHD, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-6892-3619

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseInsulinOphthalmic SolutionsAdultChronic DiseaseEye DiseasesFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedInsulinOphthalmic Solutions

Identifiers

PMID38600163
PMCPMC11226390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.